Australian
Society for Medical
Entrepreneurship
& Innovation
ASME, home
All resources
Field note6 min28 Mar 2026

Why clinician-led healthtech is leaving money on the table

Healthcare buyers expect a 15 to 25 percent volume discount at scale. 78 percent of SaaS companies now price on value rather than cost.

By ASME Editorial

Field note

The pricing instinct gap

Clinicians are trained inside a system in which professional value is reimbursed at rates someone else negotiates. Medicare item numbers. Hospital salary scales. College fellowship rates. By the time a clinician becomes a founder, they have spent a decade as a price-taker in their own labour market and the muscle memory shows up directly in how they price their products. The result, for many clinician-led healthtech companies, is a price floor anchored to cost-plus comparators rather than to the value the product creates for the customer.

The market has moved on from cost-plus. By 2025, 78 percent of SaaS companies primarily implement value-based pricing strategies, up from 62 percent in 2023, according to the Monetizely SaaS Pricing Benchmark Study. SaaS companies that price on value report 30 percent higher revenue growth from enterprise customers than peers using cost-plus models.

What healthcare buyers actually expect

Healthcare buyers do not expect to pay list. The same Monetizely analysis cites HIMSS data showing that hospital and health-system buyers typically expect volume discounts of 15 to 25 percent when scaling beyond 250 beds. Companies that price at the floor have nothing to give up in negotiation, which buyers read as a small-vendor red flag rather than as principled pricing.

The implication for clinician-led companies is straightforward. Set list price at the value-based number, not the cost-plus one. Build the discount mechanic into the contract structure. Let enterprise procurement teams claim the discount they expect. The price the customer actually pays is the same price you would have charged from a cost-plus floor, but the negotiation is healthier and the perceived value is higher.

Value-based pricing has moved on

Bessemer Venture Partners' health-tech atlas tracks the metrics growth-stage healthtech companies are now expected to clear, including net revenue retention, gross margin, and the fraction of contract value tied to outcomes rather than usage. The benchmarks have tightened in 2024 and 2025 as the sector has matured.

True outcome-based pricing, where the vendor shares risk and reward with the customer based on a measurable clinical or operational metric, is now actively explored or piloted by 47 percent of SaaS companies, with 9 percent fully implemented, per the Monetizely study. For clinician-led companies, this is the pricing model the clinical training arguably equips you for better than non-clinical peers, because you can articulate the outcome metric in language the customer trusts.

A pricing audit grounded in real benchmarks

Map the customer's existing cost stack. Labour, software, error rate, opportunity cost. Aim for a dollar figure within thirty percent. If you cannot get to a number, you have not done the work yet, and the price is anchored on instinct.

Calculate your share of the saving. The sector rule of thumb is twenty-five to forty percent of the customer's saving accrues to the vendor. If you are at single-digit share, the customer is not getting a deal. They are getting a charity, and they will likely overconsume the product, which raises your support burden without raising your revenue.

Benchmark against the Bessemer healthtech metrics. Net revenue retention above 110 percent. Gross margin above 70 percent. If the metrics fall short, the price is one of the most likely causes, ahead of churn or product gaps in most cases.

The renewal mechanic that protects the relationship

Mid-contract price increases break trust. Renewal price increases, set up at signing, are standard for enterprise SaaS and should be standard for clinician-led healthtech. The minimum is an annual review with a CPI floor. The better mechanic is CPI plus a fixed margin (typically 4 to 6 percent), reviewed annually and indexed to a published outcome metric the customer can verify.

Companies that have priced for value from the first contract and built the renewal mechanic into the standard agreement do not need to reprice their existing book. They get the uplift on schedule. Companies that priced cost-plus at the floor and hope to reprice mid-cycle will not recover the gap, even after several years.

Sources

  1. 01Monetizely, SaaS Pricing Benchmark Study 2025
  2. 02Monetizely, Testing Healthcare SaaS Pricing Strategies (HIMSS data)
  3. 03Bessemer Venture Partners, Benchmarks for growing health tech businesses
  4. 04MTPConnect, Australian medtech, biotech and pharmaceutical sector reporting

Written by ASME Editorial · Published 28 Mar 2026